| scholarly article | Q13442814 |
| P50 | author | Joseph W Kim | Q96166865 |
| P2093 | author name string | Daniel P Petrylak | |
| Insoo Kang | |||
| Min Sun Shin | |||
| Youna Kang | |||
| P2860 | cites work | Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant | Q24655036 |
| Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy | Q27001216 | ||
| PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations | Q28075712 | ||
| Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis | Q28246778 | ||
| Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes | Q28282689 | ||
| Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 | ||
| Alpha emitter radium-223 and survival in metastatic prostate cancer | Q29617472 | ||
| The immune contexture in human tumours: impact on clinical outcome | Q29620667 | ||
| Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens. | Q33878572 | ||
| Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired | Q34080914 | ||
| Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients | Q34161579 | ||
| Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer | Q34415510 | ||
| Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. | Q34546812 | ||
| Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 | ||
| Th17 and natural Treg cell population dynamics in systemic lupus erythematosus | Q34978528 | ||
| NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy | Q35059990 | ||
| Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer | Q35463514 | ||
| Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy | Q35540109 | ||
| Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial | Q35567212 | ||
| Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc | Q35958174 | ||
| The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing | Q36126003 | ||
| In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer | Q36210670 | ||
| PD-1 and PD-1 ligands: from discovery to clinical application | Q36868261 | ||
| IL-7 and IL-15: biology and roles in T-Cell immunity in health and disease | Q37376341 | ||
| Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells | Q37525422 | ||
| Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing | Q37660302 | ||
| Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial | Q37684364 | ||
| Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial | Q38212374 | ||
| Targeting of IL-4 and IL-13 receptors for cancer therapy | Q38531637 | ||
| IL‐13 regulates cancer invasion and metastasis through IL‐13Rα2 via ERK/AP‐1 pathway in mouse model of human ovarian cancer | Q39486476 | ||
| Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes | Q40497215 | ||
| Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer | Q41084285 | ||
| PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis | Q51610294 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e469-e476 | |
| P577 | publication date | 2017-10-24 | |
| P1433 | published in | Clinical Genitourinary Cancer | Q332266 |
| P1476 | title | Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer | |
| P478 | volume | 16 |
| Q92657898 | Advances in targeted alpha therapy for prostate cancer | cites work | P2860 |
Search more.